Mettler-Toledo International, Inc. MTD
1,511.64
(7.51)
(0.49%)
as of 25 Sep
- Market cap
- $30.4B
- P/E
- 33.9×
Follow MTD
Indexes
indicate stock being part of an index
Mettler-Toledo International, Inc. (MTD) Revenue growth
Mettler-Toledo International, Inc.'s revenue growth over the twelve months to 30 June 2026 was 6.91%, up 2.9 percentage points from fiscal 2025 (3.98%). Over the past ten years it has ranged from −3.64% (fiscal 2015) to 20.5% (fiscal 2021); the current reading is higher than 55% of that period. That is below the Diagnostics & Research industry median of 7.69% and below the Healthcare sector median of 8.26%.
Revenue growth, annual
Annual
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 3.98% | 1.76 |
| FY2024 | 2.22% | 5.57 |
| FY2023 | −3.35% | (8.78) |
| FY2022 | 5.43% | (15.08) |
| FY2021 | 20.5% | 17.97 |
| FY2020 | 2.54% | 0.05 |
| FY2019 | 2.49% | (5.24) |
| FY2018 | 7.73% | (0.91) |
| FY2017 | 8.64% | 3.93 |
| FY2016 | 4.71% | 8.35 |
Quarterly
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 4.48% | (2.69) |
| Mar 2026 | 7.17% | (0.93) |
| Dec 2025 | 8.10% | 0.23 |
| Sep 2025 | 7.87% | 4.02 |
| 42 more quarters | Free account |
Against its own ten years
Low −3.64%
High 20.5%
Ten-year median
3.98%
Current reading's percentile
55
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| WAT Waters Corporation compare | 52.5% |
| GH Guardant Health, Inc. compare | 42.7% |
| IDXX IDEXX Laboratories, Inc. compare | 12.8% |
| DGX Quest Diagnostics Incorporated compare | 9.87% |
| A Agilent Technologies, Inc. compare | 8.60% |
| IQV IQVIA Holdings Inc. compare | 8.17% |
| MTD Mettler-Toledo International, Inc. | 6.91% |
| LH Labcorp Holdings Inc. compare | 6.41% |
| ILMN Illumina, Inc. compare | 4.88% |
| Diagnostics & Research industry median | 7.69% |
| Healthcare sector median | 8.26% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on MTD
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- The full statement